Open the mobile version, with barcode scanning
Class II Ongoing

Clindamycin Phosphate in 0.9% Sodium Chloride Injection, 600 mg per 50 mL (12 mg/mL), 50 mL Single-Dose GALAXY Container, Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation, Deerfield, IL 60…

Why: CGMP Deviations

Company
Baxter Healthcare Corporation
Deerfield, IL, United States
Reported
Sep 9, 2026
Recall started
Aug 6, 2026
Where sold
US Nationwide; Puerto Rico; and Chile.
Amount
N/A
Full product description
Clindamycin Phosphate in 0.9% Sodium Chloride Injection, 600 mg per 50 mL (12 mg/mL), 50 mL Single-Dose GALAXY Container, Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-9549-50.
Lots / codes affected
Lot # NC193689, Exp Date: 10/16/2027.

Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.